drugset / Trial / NCT02450526

Dysport in the Treatment of Glabellar Lines in Chinese Subjects

NCT02450526

Phase 3 Completed 520 enrolled Ipsen
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to demonstrate the efficacy of Dysport for the improvement in appearance of moderate to severe glabellar lines and to assess the short term and long term safety of Dysport, used for the improvement in appearance of moderate to severe glabellar lines in Chinese subjects.

Timeline

Start
2015-04
Primary completion
2016-07
Completion
2017-09-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 20 unknown
Comparator Botulinum toxin type A Protein / enzyme biologic 50 unknown

Indications

No indication recorded.